Sign In
Buy ATNF
$7.04
+0 (+0%)
At Close: Nov 14, 2025
180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address at the 2021 International Dupuytren Symposium
08:15am, Thursday, 18'th Nov 2021
‘Re-purposing anti-TNF for Dupuytren's Disease' Being Presented Wednesday, December 1, 2021, at 3pm EST ‘Re-purposing anti-TNF for Dupuytren's Disease' Being Presented Wednesday, December 1, 2021,
180 Life Sciences Stock Bounces Off Support: What's Next?
03:16pm, Monday, 18'th Oct 2021
180 Life Sciences Corp. (NASDAQ:ATNF) shares are trading higher Monday, although there looks to be no company-evident news to explain the jump in price. The stock was trending on social media sites th
180 Life Sciences Corp. Continues To Expand Intellectual Property Portfolio
08:30am, Thursday, 30'th Sep 2021
Notice of Allowance Issued for “Method for Reducing Post-Operative Cognitive Dysfunction (POCD)” Notice of Allowance Issued for “Method for Reducing Post-Operative Cognitive Dysfunction (POCD)�
Three Anti-TNF Product Candidates To Be Included in Expected Global Agreement Three Anti-TNF Product Candidates To Be Included in Expected Global Agreement
180 Life Sciences: Looking At Inflammation With Cannabis (Podcast Transcript)
04:08pm, Monday, 13'th Sep 2021
180 Life Sciences: Looking At Inflammation With Cannabis (Podcast Transcript)
180 Life Sciences: Looking At Inflammation With Cannabis (Podcast)
06:00pm, Wednesday, 08'th Sep 2021
180 Life Sciences' Prof. Sir Marc Feldmann, who co-founded ATNF with cannabis trailblazer Prof. Raphael Mechoulam, joins the podcast with Dr. Jonathan Rothbard, Chief Science Officer. Focusing on pain
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
08:30am, Monday, 30'th Aug 2021
PALO ALTO, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b clinical trial,
180 Life Sciences Corp. Announces Closing of $15.0 Million Private Placement
08:30am, Tuesday, 24'th Aug 2021
PALO ALTO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the "Company"), a clinical-stage biotechnology company focused on the developmen
Why 180 Life Sciences Stock Is Falling Today
01:08pm, Thursday, 19'th Aug 2021
Another capital raise less than a year after the company's stock market debut is more than a little troubling.
180 Life Sciences Corp. Announces $15.0 Million Private Placement
09:00am, Thursday, 19'th Aug 2021
PALO ALTO, Calif., Aug. 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of n
180 Life Sciences Announces Selection of Lead Synthetic CBD Analogue
08:15am, Wednesday, 28'th Jul 2021
Collaboration Between the Pioneer of Cannabis Chemistry in Israel, Professor Raphi Mechoulam, Sir Marc Feldmann's Laboratory in Oxford, and 180 Life Sciences Scientists, Identifies a Non-Psychoactive
180 Life Science Corp Nears Key Levels And Could Breakout Soon
03:42pm, Monday, 12'th Jul 2021
180 Life Sciences Corp (NASDAQ: ATNF) shares are trading higher Monday after the company announced it regained compliance with the Nasdaq. The company was notified Jan. 6 it did not meet the listin
180 Life Sciences Regains Nasdaq Compliance for Listing Rules 5605(b)(1) and 5605(c)(2)
09:51am, Monday, 12'th Jul 2021
MENLO PARK, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the devel
180 Life Sciences Joins Russell Microcap® Index
08:15am, Monday, 28'th Jun 2021
MENLO PARK, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the devel
180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Directors
09:12am, Thursday, 10'th Jun 2021
MENLO PARK, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of
